Efficacy of Xuebijing injection for the treatment of coronavirus disease 2019 via network pharmacology
Journal Title: Traditional Medicine Research - Year 2020, Vol 5, Issue 4
Abstract
Background: To evaluate the mechanism of Chinese patent drug Xuebijing (XBJ) injection in the treatment of a new coronavirus disease 2019 (COVID-19) based on network pharmacology and molecular docking technology. Methods: The TCMSP database was employed to collect and screen the active ingredients of the Chinese herb contained in the XBJ injection. The GeneCards database and STRING database were applied to collect and expand the targets of COVID-19 and compare and screen the related targets of COVID-19 by XBJ injection. Cytoscape was employed to build a network connecting Chinese medicine, compounds, targets, disease, and topology analysis was performed via the Network Analyzer to screen the key ingredients and targets. The software of Schrödinger molecular docking was used to verify the binding activity of the key ingredients of XBJ injection and the key targets of COVID-19. Metascape platform and DAVID database were utilized to conduct Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes analysis on the key targets of COVID-19 treated by XBJ injection. Results: Eight key compounds and 15 key targets were screened and verified by molecular docking; these key compounds included luteolin, quercetin, baicalein, and kaempferol. The key targets included DPP4, AR, ESR1, CALM1, and protein kinase 1. Gene Ontology analysis involved an apoptosis and hypoxia reaction and the changes in blood vessel morphology. Kyoto Encyclopedia of Genes and Genomes analysis involved signaling pathways of hypoxia inducible factor-1, VEGF, and PI3K/AKT/NF-κB. Conclusion: The mechanism of XBJ injection when used to treat COVID-19 should be further investigated as the key compounds in XBJ regulated the expression of key targets such as protein kinase 1, VEGF-A, B-cell lymphoma-2, and TNF, which affected the COVID-19 receptors such as angiotensin-converting enzyme 2 and signaling pathways like hypoxia inducible factor-1, PI3K-Akt, and NF-κB, which alleviated the inflammation, respiratory distress, and hypoxia caused by COVID-19 infection.
Authors and Affiliations
Yu-Liang Zhang,Qian Cui,Dou Zhang,Xin Ma,Guo-Wei Zhang
Keywords
Related Articles
- EP ID EP683786
- DOI 10.12032/TMR20200507178
- Views 192
- Downloads 0
Investigation of in vitro antioxidant activity of dihydromyricetin and flavonoids rich extract from vine tea (Ampelopsis grossedentata)
Background: Vine tea from fermented Ampelopsis grossedentata leaves has been used as a herbal tea and folk medicine in the southern region of China for hundreds of years. The aim of this investigation was to analyze the...
Experimental research of integrative Chinese medicine in multiple sclerosis
Multiple sclerosis (MS) is a severe neurodegenerative disease which brings overwhelming sufferings to patients and their families with no radical cure heretofore. Thus, studies of different medicine field and diverse tre...
Medical workers in traditional medicine who sacrificed their lives in the battle against COVID-19 deserve to be remembered forever
China held a national day of mourning on April 4, 2020 to commemorate 3,335 victims of the COVID-19 outbreak, including medical workers who sacrificed their lives in the battle against the epidemic. April 4 was also Tomb...
Epigenetic regulations of hematopoietic stem cells ageing and the regulation of traditional Chinese medicine
The current progress in the study of DNA methylation and histone modifications regulating HSCs ageing and the epigenetic role of TCM in the treatment of hematological malignancies were summarized. Age-related defects...
Chen Shi Yang Xue An Shen Tang
Sheng Long Chi (Apatite) 30g, Chao Suan Zao Ren (Semen Ziziphi Spinosae) 15g, Jiao Yuan Zhi (Radix Polygalae) 10g, Zhi Shou Wu (Radix Polygoni Multiflori Preparata) 10g, Gou Qi Zi (Lycium barbarum) 10g, Bai Shao (Radix P...